XML 155 R139.htm IDEA: XBRL DOCUMENT v3.25.0.1
LEGAL PROCEEDINGS - Intellectual Property (Details)
1 Months Ended 12 Months Ended
Feb. 19, 2025
proceeding
Feb. 11, 2025
Feb. 05, 2025
Nov. 07, 2024
Nov. 01, 2024
Sep. 27, 2024
Apr. 05, 2024
Sep. 10, 2021
Feb. 17, 2020
Mar. 31, 2021
proceeding
defendant
Dec. 31, 2024
proceeding
Norwich I Xifaxan Litigation                      
Legal proceedings and other matters                      
Stay of the approval period                 30 months    
Amneal Xifaxan Litigation                      
Legal proceedings and other matters                      
Stay of approval, period             30 months        
Zydus Xifaxan Litigation                      
Legal proceedings and other matters                      
Stay of approval, period           30 months          
Cipla Anticipated Xifaxan Litigation                      
Legal proceedings and other matters                      
Stay of the approval period         30 months            
Carnegie Anticipated Xifaxan Litigation                      
Legal proceedings and other matters                      
Stay of the approval period       30 months              
Mylan Anticipated Xifaxan Litigation | Subsequent Event                      
Legal proceedings and other matters                      
Stay of the approval period   30 months                  
The Anticipated Cabtreo Paragraph IV Proceedings | Subsequent Event                      
Legal proceedings and other matters                      
Stay of the approval period     30 months                
PreserVision® AREDS Patent Litigation | Pending Litigation | Bausch + Lomb                      
Legal proceedings and other matters                      
Number of defendants | defendant                   20  
Number of proceedings                   17  
PreserVision® AREDS Patent Litigation | Pending Litigation | Bausch + Lomb | Subsequent Event                      
Legal proceedings and other matters                      
Number of defendants 1                    
PreserVision® AREDS Patent Litigation | Settled Litigation | Bausch + Lomb                      
Legal proceedings and other matters                      
Number of defendants                     14
PreserVision® AREDS Patent Litigation | Default Judgement | Bausch + Lomb                      
Legal proceedings and other matters                      
Number of defendants                     2
Lumify Paragraph I V Proceedings Slayback ANDA Litigation | Bausch + Lomb                      
Legal proceedings and other matters                      
Stay of the approval period               30 months